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Abstract
Enterotoxins increase intestinal fluid secretion through modulation of ion channels as well as
activation of the enteric nervous and immune systems. Colonic organoids, also known as
colonoids, are functionally and phenotypically similar to in vivo colonic epithelium and have been
used to study intestinal ion transport and subsequent water flux in physiology and disease models.
In conventional cultures, organoids exist as spheroids embedded within a hydrogel patty of
extracellular matrix, and they form at multiple depths, impairing efficient imaging necessary to
capture data from statistically relevant sample sizes. To overcome these limitations, an analytical
platform with colonic organoids localized to the planar surface of a hydrogel layer was developed.
The arrays of densely packed colonoids (140 μm average diameter, 4 colonoids/mm2) were
generated in a 96-well plate, enabling assay of the response of hundreds of organoids so that
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analysis platform efficiently tracked over time swelling due to forskolin and fluid movement across
the cell monolayer stimulated by cholera toxin. The platform was used to screen compounds
associated with the enteric nervous and immune systems for their effect on fluid movement across
epithelial cells. Prostaglandin E2 promoted increased water flux in a subset of organoids that
resulted in organoid swelling, confirming a role for this inflammatory mediator in diarrheal
conditions but also illustrating organoid differences in response to an identical stimulus. By
allowing sampling of a large number of organoids, the arrayed organoid platform permits
identification of organoid subpopulations intermixed within a larger group of nonresponding
organoids. This technique will enable automated, large-scale screening of the impact of drugs,
toxins, and other compounds on colonic physiology.
Infectious diarrheas caused by bacterial production of enterotoxins are common diseases
worldwide. Enterotoxins such as cholera toxin, produced by the bacterium Vibrio cholerae, interact
with intestinal epithelial cells to increase the movement of water and ions into the intestinal lumen,
the consequence of which is severe diarrhea.(1) Cholera toxin acts through a series of steps that
include binding of the toxin to the surface of epithelial cells, endocytosis, and a series of enzymatic
reactions that result in release of cholera toxin A1 (CTA1) chain, which binds to the intracellular
protein ADP-ribosylation factor 6 (Arf6), resulting in CTA1 activation.(2) Through an additional
series of enzymatic steps, CTA1 increases the activity of the Gs α subunit (Gαs) proteins, leading
to increased adenylyl cyclase activity that results in an elevation in 3′,5′-cyclic adenosine
monophosphate (cAMP) concentration more than 100-fold higher than normal, leading to
increased activity of protein kinase A (PKA). Phosphorylation of the cystic fibrosis transmembrane
conductance regulator (CFTR) chloride channel proteins by PKA then leads to ATP-mediated
efflux of chloride ions, resulting in the movement of H2O as well as sodium, potassium, and
bicarbonate ions into the intestinal lumen.(1, 3, 4) The calcium-activated chloride channel (CLCA)
can also cause fluid migration in response to toxin-mediated increase in the concentration of
intracellular Ca2+.(5) Other enterotoxins also secreted by the Vibrio bacterium are known to
activate the enteric nervous and immune systems, producing agonists such as prostaglandins,
acetylcholine, and histamine, which can also participate in intestinal ion and water movement
through intracellular cAMP or Ca2+ signaling.(1) The synergistic impact of enterotoxin-mediated
effects increases intestinal secretion, yielding rapid and cumulative fluid loss of up to 2 L/h into the
intestine, causing severe dehydration that may result in death.(6)
To study intestinal ion secretion and fluid movement, tissue-cultured tumor cell lines are often used
as surrogate intestinal cells. However, the genetic profile and functional properties of tumor cells
do not match those of primary tissue.(7) Intestinal organoids derived from primary cells offer a
more accurate functional model of in vivo tissue physiology compared to tumor cells.(8, 9)
Proliferative organoids are readily cultured from crypts or stem cells isolated from the intestine and
are maintained by culture within a thick layer of hydrogel (typically Matrigel) in the presence of a
medium rich in growth factors.(10) The organoids possess all cell types of the intestine, including
stem/proliferative cells, enterocytes, and goblet cells. These cells form a monolayer surrounding a
central lumen and are polarized so that their luminal surface faces into the central cavity while the
basal cell surface makes contacts with the extracellular matrix proteins within the surrounding
hydrogel. This cell polarity enables the organoids to retain many physiologic functions such as
transport of ions across the monolayer.(8, 11) Contact between the basal, cell-surface proteins
and the extracellular matrix is thought to be required to provide the correct mechanical and
chemical environment for proper organoid formation, monolayer polarity, and ion transport
function.(8, 12, 13)
Intestinal organoids have been used for nutrient,(14) P-glycoprotein (P-gp),(15) and ion transport
assays.(11) When ions are secreted by the monolayer, water follows by a passive mechanism
termed osmosis. When sufficient numbers of ions are secreted, the increase in luminal volume
due to water movement results in swelling of these spheroidal structures and an increase in the
organoid’s cross-sectional area. This area increase can be measured directly(11, 16) or
indirectly(17) when imaged by microscopy. This phenomenon has enabled intestinal organoids to
be used in the study of drug effects, genetic mutation impact, and toxin effect on ion secretion in
the organoids.(11, 16, 18-20) However, embedding the organoids fully within a hydrogel poses a
number of challenges to increasing the assay throughput.(21) The organoids cultured in a Petri
dish or multiwell plate are typically positioned at random locations along the x, y, and z axes of the
thick hydrogel layer, leaving the organoids in varying image planes when viewed by microscopy.
This creates two challenges that severely limit assay speed: (i) organoids that are out of focus
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would increase the numbers of organoids per well that are suitable for assay and increase
experimental throughput. A second disadvantage is that compounds and drugs must diffuse
through the hydrogel to access the organoid. Interactions of molecules with Matrigel can impose a
time delay in compounds reaching the organoid or decrease the concentration of compound at the
organoid’s location. Thus, compound–Matrigel interactions represent an uncontrolled variable in
organoid experiments.
We describe the development of a method to create a planar array of colonoids where the
colonoids are located on the surface of a hydrogel and compatible with automated image-based
assays. Properties of the surface-positioned colonoids were compared to those of hydrogel-
embedded organoids. Software to perform organoid segmentation and separation of nearby
organoids, as well as identification of the colonoid location, was implemented. An automated
analysis pipeline identified and quantified the properties of organoids over time and was compared
to manual identification and measurement. Colonoid swelling in response to forskolin, cholera
toxin, and physiologic molecules was assessed to characterize the extent and heterogeneity of
swelling in a population of organoids as well as the rate of fluid movement across the organoid
wall. This approach should enable efficient, large-scale screening of the impact of drugs, toxins,
and other compounds on colonoid physiology.
Experimental Section
Materials
Polystyrene 96-well plates were purchased from Denville Scientific, Inc., Holliston, MA.
Transwells, Matrigel, ethylenediaminetetraacetic acid (EDTA), 4-(2-hydroxyethyl)-
1-piperazineethanesulfonic acid (HEPES), and gentamicin were purchased from Corning.
Dimethyl sulfoxide (DMSO) was acquired from Santa Cruz Biotechnology, Dallas, TX. Optimum
cutting temperature (OCT) formulation was obtained from Tissue-Tek, Sakura Finetek USA, Inc.,
Torrance, CA. Na2HPO4, KH2PO4, NaCl, KCl, advanced Dulbecco’s modified Eagle medium
(DMEM)/F-12 medium, dithiothreitol (DTT), GlutaMAX, penicillin, and streptomycin were from
Thermo Fisher Scientific, Waltham, MA. Epidermal growth factor (EGF), N-acetylcysteine,
sucrose, ඌ-sorbitol, cholera toxin and its subunit B, bradykinin, prostaglandin E2, adenosine,
serotonin, acetylcholine, and histamine were purchased from Sigma, St. Louis, MO. Vasoactive
intestinal peptide was purchased from AnaSpec, Fremont, CA. Fetal bovine serum (FBS) was
obtained from Atlanta Biologicals, Flowery Branch, GA. Collagenase type IV was purchased from
Worthington Biochemical Corp., Lakewood, NJ. Information for staining and assay kits is provided
in the relevant subsections.
Isolation of Crypts from Mouse Colon and Initial Culture
The cytomegalovirus enhancer plus chicken actin promoter (CAG)-DsRed mouse model, in which
all cells expressed the DsRed fluorescent protein, and wild-type (WT) mice were used for
experiments.(22, 23) All experiments and animal usage were in compliance with the University of
North Carolina animal care protocol and were approved by the Institutional Animal Care and Use
Committee (IACUC). Mice heterozygous for DsRed expression were bred on a CD-1 background,
and WT mice were bred on a C57BL/6 background. Mice (male and female, ages 6–10 weeks)
were humanely euthanized by a lethal dose of isoflurane followed by cervical dislocation under the
UNC IACUC-approved protocol 13-200. A detailed procedure for crypt isolation and culture was
previously reported.(24, 25) Briefly, a colon was surgically extracted from a mouse following
euthanasia. The colon was then opened longitudinally and incubated with EDTA (2 mM) and DTT
(0.5 mM) in isolation buffer (5.6 mM Na2HPO4, 8.0 mM KH2PO4, 96.2 mM NaCl, 1.6 mM KCl, 43.4
mM sucrose, and 54.9 mM ඌ-sorbitol at pH 7.4) for 75 min at room temperature prior to isolation of
crypts. Then the tissue was vigorously shaken in a conical tube with isolation buffer to release the
crypts from the underlying stroma. Released crypts were pelleted by centrifugation and mixed with
Matrigel (2500 crypts in 100 μL of Matrigel) on ice (4 °C). Aliquots (10 μL) of this mix were plated
in wells of a 24-well plate, and the plate was immediately inverted to prevent any contact between
tissue pieces and the polystyrene surface. The Matrigel was then cured at 37 °C in a cell culture
incubator for 15 min. These cultures were subcultured up to 5 times.
Both embedded and arrayed cultures were grown in medium rich in growth factors, termed stem
cell medium (SM). SM was prepared by diluting Wnt 3A, R-spondin 2, and Noggin conditioned
medium in advanced DMEM/F-12 basal medium and adding necessary nutrients and buffers. Final
concentrations of each growth factor were Wnt 3A (80 ng/mL), R-spondin 2 (38 ng/mL), Noggin
(36 ng/mL), GlutaMAX (1×), HEPES (10 mM), N-acetylcysteine (1.25 mM), murine EGF (50
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concentration of Wnt 3A was determined by a Wnt 3A enzyme-linked immunosorbent assay
(ELISA) kit (LifeSpan BioSciences, Inc., Seattle, WA). R-spondin 2 and Noggin growth factor
concentrations were measured as described previously.(22) The assay medium contained the
same nutrients and buffers in similar concentrations to SM except Wnt 3A (26 ng/mL), R-spondin 2
(30 ng/mL), and Noggin (56 ng/mL).
Generation of Arrayed Colonoids
A planar biomimetic scaffold composed of Matrigel (protein concentration 9.2 mg/mL) was
prepared in a multiwell plate. For a 96-well plate, 75 μL of Matrigel was dispensed to each well,
and for 12-well Transwell plates, 200 μL of Matrigel was dispensed to produce a Matrigel layer 2.4
mm thick. The plate was centrifuged for 1.5 min at 2000 relative centrifugal force (rcf) at 1 °C. The
plate was transferred to a 37 °C cell culture incubator for 10 min for Matrigel gelation. To grow
organoids on these surfaces, colonoids grown in a Matrigel patty were isolated by incubation with
collagenase (type IV, 500 units/mL) to break up the Matrigel. After release of colonoids from the
hydrogel, the colonoids were gently mechanically dissociated. Fragmented colonoids (≤50 μm in
diameter) containing cells derived from a WT or CAG Ds-Red mouse were added to the surface of
a Matrigel-filled well as a suspension (120 000 cells) in SM. The number of cells in the isolated
colonoids was calculated by CellTiter-Glo luminescence cell viability assay (Promega US,
Madison, WI) according to the manufacturer’s protocol. Over the first 24 h in culture, colonoid
fragments (≤50 μm diameter) were allowed to adhere to the Matrigel layer. Over the course of the
subsequent 2–3 days, these fragments developed into colonoids ≥100 μm in diameter. Arrays
were imaged on a Nikon Eclipse TE300 inverted epifluorescence microscope with an estimated
objective depth of field of >59 μm [numerical aperture (NA) 0.13] for comparison with three-
dimensional (3D) embedded cultures. The viability of colonoids after culturing 72 h on an array
was measured by use of propidium iodide (PI) as a marker of cells’ death and Hoechst 33342 as a
counterstain. After 72 h of culture, 100% of the colonoids were viable.
Colonoid Characterization
Colonoids were grown on the surface of Matrigel layered onto the membrane of a 12-well
Transwell insert. After the colonoids were cultured for 3 days, the array was fixed with 4%
paraformaldehyde for 25 min. The array was incubated with 30% sucrose for 3 h and kept in OCT
formulation overnight. The membrane was cut out of the inset, and the tissue was sectioned with a
cryostat to obtain 10 μm thick slices. These slices were stained with fluorescently labeled
phalloidin for F-actin (ActinGreen 488, Molecular Probes, Thermo Fisher Scientific, Waltham, MA)
and Hoechst 33342 and then imaged by fluorescence microscopy.
Cell Lineages in Arrayed Colonoids
To mark S-phase cells, 5-ethynyl-2′-deoxyuridine (EdU, 10 μM in SM) was incubated on the arrays
for 4 h. The arrays were then fixed in 4% paraformaldehyde for 20 min and incubated with 0.5%
Triton X-100 for 20 min to facilitate diffusion of the labeling reagents into the cells. EdU-marked
cells were then stained by use of a Click-iT EdU Alexa Fluor 647 imaging kit (Thermo Fisher
Scientific, Waltham, MA). Next, the goblet cells were stained with rabbit anti-mucin2 (α-Muc2,
1:200, Santa Cruz Biotechnology, Inc., Dallas, TX, sc-15334).(26) A secondary antibody, Alexa
Fluor 488 α-rabbit (1:500, Jackson Immunoresearch, West Grove, PA, 711-545-152), was used to
fluorescently label the primary antibody. Stained colonoids were imaged on a Nikon Eclipse TE300
inverted epifluorescence microscope with an estimated objective depth of field of >11 μm (NA 0.3).
Automated Fluorescence Imaging of Arrayed Colonoids
Automated imaging of arrayed colonoids was performed on an Olympus IX81 inverted
epifluorescence microscope with a 4× objective (Olympus UPlanFL N, NA 0.13 with an estimated
objective depth of field of 40 μm) and a CoolSNAP HQ2 charge-coupled device (CCD) camera
(Photometrics, Tucson, AZ) or Hamamatsu Flash 4.0 VZ (Hamamatsu, Japan). Colonoids in this
study were fluorescently labeled, either by labeling with Hoechst 33342 to stain DNA or by using
colonoids derived from CAG-DsRed mouse model in which all cells expressed the DsRed
fluorescent protein. For fluorescence imaging of DSRed and Hoechst 33342, Chroma ET-YFP
49003 and Chroma ET-DAPI 49000 filters were used, respectively. The microscope was equipped
with a humidified incubation chamber to maintain an environment at 5% CO2 and 37 °C. All
automated image acquisition was controlled by a custom MATLAB program (MATLAB 2014b, The
MathWorks, Inc., Natick, MA) harnessing Micro-Manager microscopy software. Individual wells
within plates were imaged with overlapping fields of view (i.e., 6 × 4 image tiling to cover a single
well of a 96-well plate).
Despite the curved shape of the Matrigel substrate (a concave meniscus measuring 595 ± 84 μm
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compensate for any curvature of the Matrigel surface upon which the arrayed colonoids were
cultured. First, prior to image acquisition, an autofocus scan of the colonoid array was performed
to determine focal positions for each desired imaging region throughout the array. A software-
based autofocus was used that maximized the standard deviation of the pixel intensity in
fluorescence images of the colonoids. To further guarantee well-focused images, 40% image
overlap was employed during mosaicking and only the highly focused, central nonoverlapped
portion of each image was used for subsequent analysis. Once the imaging positions were
determined by utilizing these approaches, a 15 mm2 area composed of 4 × 6 images with 40%
overlap between fields was acquired for each well in 22 s. The 15 mm2 area was chosen to avoid
imaging too close to the well walls (well area 32 mm2 for 96-well plates).
Image Analysis and Assay Metrics
All image analyses were performed with custom MATLAB scripts. The analyses began by forming
full-well images by stitching together the well-focused central portions of the images from a well.
Colonoids were identified by segmenting the Hoechst or DsRed fluorescent images by use of
Otsu’s automatic intensity thresholding.(27) For some colonoids the fluorescence labeling was
dim, which interfered with basic intensity-thresholded segmentation. For these colonoids, intensity
thresholding did not detect the full colonoid boundary, and thus the segmentation was
discontinuous when in reality the colonoids had an intact and continuous border. To compensate, a
morphological closing operation using a disk of 19 μm radius (3 pixels) was applied. Objects below
100 μm in effective diameter were removed to eliminate debris, dead cells, and organoid
fragments. Segmentation holes were filled and adjacent colonoids were separated by a geometric
watershed transform.(28) Colonoid centroids, areas, and mean fluorescence intensities were
automatically recorded within the colonoid boundaries identified in the final segmentation masks.
To track colonoid properties over time, an algorithm was constructed to match the colonoids in the
images acquired at different time points. Every identified colonoid’s centroid was measured at
each time point. When colonoids were tracked over time, colonoids whose centroids varied less
than 100 μm along the plane of the array and whose areas varied by less than 25% between time
points were considered to be the same colonoid. In the event of temporal gaps in the tracking of a
colonoid, the algorithm linearly interpolated colonoid measurements for up to two time points.
Colonoids with three or more untracked time points were excluded from analysis.
Several metrics were used to quantify changes in colonoid size over time. The magnitude of the
change in a colonoid’s area was measured as the percent area increase relative to the initial area
(ΔA, expressed as a percentage) or maximal value of ΔA during the assay time (ΔAmax,
expressed as a percentage). The initial rate of size increase of colonoids was quantified as the
slope of a linear fit (R2 > 0.85) of area as a function of time. With the assumption that colonoids
are spherical and swell isotropically, area rates of change could be converted into net fluid flux
occurring between time points 1 and 2 according to
where Vi and Ai represent the colonoid volume and colonoid surface at times 1 and 2 (ti). To
cluster colonoid subpopulations, an expanded 10-dimensional data set was extracted per colonoid
(see Supporting Information). Supervised clustering to classify individual colonoids into
nonresponsive (i.e., negative control-like) or responsive (i.e., positive control-like) groups was
performed with a binary linear support vector machine classifier (MATLAB’s fitcsvm).(29)
Unsupervised clustering was performed via k-means clustering with k = 2. For classification, each
dimension of the data was centered and scaled by the mean and standard deviation. Classification
accuracy was estimated by five cross-validation folds.
cAMP-Stimulated Transport
Colonoids at day 2 of growth on the array were used for all fluid transport assays since these
colonoids are composed primarily of stem/proliferative cells, which are thought to play a major role
in fluid secretion.(30) Wild-type colonoids were stained with Hoechst 33342 (2 μM in assay
medium) for 25 min. Forskolin was used for activation of adenylyl cyclase to increase the
intracellular cAMP concentration. Forskolin (1 μM), cholera toxin (CT, 5 or 0.5 μg/mL) or subunit B
of CT (C-B, 5 or 0.5 μg/mL) in assay medium was added to arrayed colonoids, which were then
immediately imaged every 3 min for 1–1.5 h. DMSO, in an amount equivalent to that in added
forskolin, was added to control wells. The viability of colonoids after 48 h on the array with and
without an additional 1 h forskolin challenge was measured by use of propidium iodide to assay
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Figure 1. Generation and characterization of arrayed colonoids and comparison to
embedded colonoids. (A) Work flow for generating the arrayed colonoids. (B)
Bright-field image of an individual colonoid within the array. (C) F-actin (green) and
Hoechst (blue) stained cryosectioned image of an arrayed colonoid. (D)
Cryosectioned bright-field image of an arrayed colonoid. (E, F) EdU (green), MUC2
(red), and Hoechst (blue) stained images of (E) arrayed and (F) embedded
colonoids. (G) Percent normalized area positive for EdU or MUC2 fluorescence in arrayed and embedded
organoids. All scale bars represent 75 μm.
forskolin- and DMSO-treated samples.
Investigation of Fluid Movement Using Compounds of the Enteric Nervous and Immune Systems
Eight compounds that are known to be associated with cAMP- or Ca2+-regulated ion transport
were assessed for their ability to induce fluid movement into the colonoids, leading to colonoid
swelling (Table S1). All compounds except forskolin were dissolved in 1× phosphate-buffered
saline (PBS) or distilled water and diluted 1000× in assay medium prior to addition to the
colonoids. Forskolin was dissolved in DMSO and diluted 1000× in assay medium. Addition of
assay medium or DMSO (0.1%) was used as a control. After being cultured for 2 days in SM,
colonoids were stained with Hoechst 33342 for 25 min. The medium in each well was then
replaced with the appropriate experimental or control medium and the plate was transferred to the
microscope for time-lapse fluorescence imaging every 3.6 min for 32 min. Compound screening
was performed in triplicate by culturing arrayed colonoids in three 96-well plates utilizing 16 wells
within each plate: one for each of the eight compounds to be screened; one each for the forskolin
and cholera toxin positive and negative controls, respectively; five for the assay medium controls;
and one for the DMSO control. To control for plate-to-plate variance, each plate used a random
well order for the compounds.
Statistical Analysis
Unless otherwise specified, data are presented as the sample mean and standard deviation. Two-
tailed t-tests were utilized for comparisons between two groups. Statistical analyses of multiple
experimental groups and controls were performed by one-way analysis of variance (ANOVA) and
Tukey’s test for multiple comparisons. For statistical analysis of multiple experimental groups
between embedded and arrayed organoids, two-way unbalanced ANOVA with type III sum of
squares and Tukey’s test for multiple comparisons were used. All statistical tests were performed
at a significance level of 0.05 and were computed by MATLAB or GraphPad Prism (GraphPad
Software, Inc. La Jolla, CA). G*Power software (Heinrich Heine University) was used for a priori
sample size determination based on a two-tailed t-test for differences in ΔAmax of two groups with
α = 1 – β = 0.05.
Box-and-whisker plots were used to show ΔAmax (%) of colonoids. The small box indicates the
mean of the data, the bar shows the median, and the upper and lower boxes represent the 75th
and 25th percentiles of the data, respectively. The whiskers extend to the fifth and 95th
percentiles, and × denotes outliers. For all statistical comparisons, p-values were represented as
follows: * for p < 0.05, ** for p < 0.01, *** for p < 0.001, and **** for p < 0.0001.
Results and Discussion
Generation of a Colonoid Array and Its Characterization
To generate colonoid arrays, a protocol similar to that used to create acinar cultures from tumor
cell lines was adapted for primary intestinal epithelial organoids.(13, 31) Colonoid fragments
possessing proliferative cells were plated on the surface of a layer of polymerized Matrigel. Cells
in the colonoids adhered to the upper surface of the Matrigel and expanded in size while
remaining attached to the surface (Figure 1A,B). Under these conditions, 24% ± 11% (n = 19) of
the colonoid diameter was embedded within the Matrigel, with the remainder extending above the
Matrigel surface into the overlying medium (Figure 1D). None of the colonoids (n = 70) on the
Matrigel surface overlapped in the Z dimension. In contrast, colonoids embedded in conventional
3D cultures were frequently found to overlap one another and reside in multiple focal planes
throughout the gel (Figure S1). The polarity of the cell layer surrounding the colonoid lumen was
investigated by fixing and cryosectioning the colonoids after 3 days of growth, followed by staining
F-actin with fluorescently labeled phalloidin. F-actin was localized to the inner surface of the
colonoid lumen, suggesting that the actin-rich microvilli were also located on the luminal organoid
surface and that the organoids were properly polarized (Figure 1C).(32)
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Figure 2. Automated imaging and image analysis. (A) Work flow of automated
image acquisition and analysis. (i) Arrayed colonoids are imaged over time on a
motorized wide-field microscope. (ii) A top-view image of each colonoid is
obtained. (iii) Images of the colonoids are stitched into a single image per well
(black dashed–dotted line represents well perimeter). (iv) Colonoids are
segmented by automated image analysis to produce a binary map of each
colonoid. (v) Assay metrics such as colonoid size over time are extracted. (B)
Stitched, full-well image showing DsRed fluorescence of colonoids after 3 days of growth on the array. Scale
bar represents 500 μm. (C) Box-and-whisker distributions of colonoid diameter over time. (D) Histogram of
percent of colonoids versus their percent area rate of change (%/h). (E) Time series of DsRed fluorescence
images of the single colonoid indicated by the yellow arrow in panel B. (F) Change in colonoid cross-sectional
area over time, relative to time zero. Each trace represents a single colonoid (n = 62 colonoids), with the
population median colonoid swelling represented by the black trace.
vivo. To identify cell lineages present in the arrayed colonoids, arrayed and embedded colonoids
were pulsed with EdU to identify S-phase cells and immunostained for mucin 2 (MUC2) to identify
the differentiated goblet cells. Colonoids were imaged with a fluorescence microscope. The area
of the colonoid displaying EdU-based or MUC2 immunofluorescence was quantified and
normalized to the total area of the organoid, that is, the organoid image area positive for Hoechst
33342 fluorescence. Colonoids that were cultured on the arrays in a medium rich in growth factors
(SM) displayed an EdU+/Hoechst area of 47.2% ± 24.5% (n = 27), suggesting large numbers of
S-phase or proliferative cells (Figure 1E,G). The MUC2+/Hoechst area was 0.5% ± 1.1% (n = 29),
indicating that few of the differentiated goblet cells were present under these culture conditions
(Figure 1E,G). For comparison, Matrigel-embedded colonoids cultured in the presence of the SM
possessed an EdU+/Hoechst area of 34.6% ± 22.0% (n = 25) that was not significantly different
from that of the arrayed colonoids (p = 0.852) (Figure 1F,G). Similarly, the MUC2+/Hoechst area
for the embedded colonoids (0.3% ± 0.9%, n = 25) was not significantly different than that of the
arrayed colonoids (p = 0.486) (Figure 1F,G). Thus, the arrayed colonoids displayed similar
numbers of proliferative and differentiated cells to those found in the embedded colonoids,
suggesting that the two organoid culture systems were similar. Additionally, the large standard
deviation in the area of EdU uptake and MUC2 immunostaining suggested that the colonoids
might be quite heterogeneous in their properties in both culture systems.
Automated Assay of Colonoid Arrays
Since the colonic organoids displayed heterogeneous behavior, significant sample sizes would
likely be required to identify subpopulations and/or responses to some compounds. Thus,
automated microscopy and image analysis were implemented so that hundreds of colonoids could
be assayed per experiment. A motorized microscope acquired a grid of images spanning each
well of a 96-well plate (Figure 2A). As the colonoids lay above the hydrogel surface and the
structures did not overlap, autofocus routines could be applied to rapidly image the colonoid arrays
(22 s/well). The images of each well were stitched together, followed by application of an
automated analysis pipeline (Figure 2A,B). The colonoids were segmented by use of Otsu’s
method for thresholding to create a mask for subsequent fluorescence measurements.(27) The
masks were size-filtered to remove objects less than 60 μm in diameter, and adjacent colonoids
were separated by a watershed transform.(28) Colonoid centroids, areas, and mean fluorescence
intensities were then quantified for the masked regions, and these features as well as the colonoid
location were tracked over time.
To develop the automated platform, murine colonoids expressing DsRed were cultured on the
arrays and imaged over 3 days. The wells contained a total of 214 colonoids (n = 3 wells). The
median colonoid diameter increased from 105.0 ± 12.8 to 139.0 ± 6.7 μm (p < 0.02) over the 3-day
culture time (Figure 2C–E). Between days 2 and 3, the majority of the colonoids (52.6% ± 6.5%)
experienced ≤25% increase in image plane area (Figure 2D, Video S1). The colonoids were nearly
stationary over this time with an average linear velocity of 2.8 ± 0.3 μm/h. A small percentage
(9.4%) of the colonoid population displayed >75% increase in image area during the 24 h time,
with the fastest growing colonoid expanding in area from 17 850 to 36 237 μm2 (equivalent
diameter increase from 151 to 215 μm). Most of the colonoids (95%) displayed area growth rates
<4.3%/h and absolute area growth rates <479 μm2/h.
The performance of automated image analysis of colonoid area and position was evaluated from
image data acquired between days 2 and 3 of culture (Figure 2F). The automated image analysis
routines segmented and tracked 72.6% ± 7.9% of the wells’ colonoids (154 colonoids across 3
wells). A goal of this work was to segment the entire colonoid without including adjacent colonoids
CONTINUThis website uses cookies to improve your user experience. By continuing to use the site, you are accepting our use of cookies. Read the ACS privacy policy.
Development of Arrayed Colonic Organoids for Screening of Secretagog... https://pubs-acs-org.libproxy.lib.unc.edu/doi/full/10.1021/acs.analchem....
7 of 14 1/16/2019, 3:46 PM
Figure 3. Colonoid swelling initiated by forskolin. (A) Time series of composite
DsRed fluorescence images over 1.3 h (time 0, red; other time points, cyan) of a
colonoid on an array after addition of forskolin or DMSO at time zero. (B) Bright-
field images of a colonoid after addition of forskolin (1 μM) at time zero. (C, D) ΔA
of colonoids over time when (C) forskolin (1 μM) or (D) DMSO (0.1%) was added at
time zero. k-means clustering with k = 2 was performed to classify the population
into nonresponders (red) and responders (blue). (E) Comparison of ΔA versus number of colonoids treated
with forskolin or DMSO for the data in panels C and D.
expense of excluding 22.3% ± 7.7% (49 colonoids in total) of the colonoids based upon thresholds
of allowable colonoid diameter, swelling rates, and centroid velocities. Both inaccurate
measurements and colonoid exclusion occurred predominantly when the colonoids were clustered
too densely for successful segmentation or possessed regions that fell below the fluorescence
threshold for the mask. Notably, the array with the lowest colonoid density (4 colonoids/mm2)
exhibited the fewest instances of clustered colonoids and the highest rate of accurate analysis
(81.7%). Thus, increasing the density beyond 4–6 colonoids/mm2 may have diminishing returns on
throughput when strict colonoid exclusion criteria are used in image analysis algorithms.
cAMP-Regulated Transport
Intracellular cAMP production initiates ion transport into the intestinal lumen, which is followed by
the passive movement of water into the lumen. In the colonoids, ions and fluid move into the
enclosed lumen, causing the structure to swell. To assess the cAMP-regulated transport, arrayed
colonoids were stained with Hoechst 33342 and stimulated with forskolin (0 or 1 μM), which is
commonly used to stimulate the production of cAMP by adenylyl cyclase in cells. The colonoids
were imaged over time with the automated platform, and Hoechst fluorescence was used to
identify and segment the colonoids. Addition of forskolin to cells resulted in a visible increase in
colonoid diameter in less than 1 h, while the DMSO control had no impact on the structures
(Figure 3A,B). Colonoid area was tracked over time to determine net rate of fluid movement
across the monolayer of colonic epithelial cells (Figure 3C–E). The percent maximal area
increase, ΔAmax, of forskolin-treated colonoids was 21.2% [5.3%, 41.9%] (presented throughout
as median [25th, 75th percentile]; here n = 66 colonoids) relative to their area prior to forskolin
addition (Video S2). In contrast colonoids receiving medium or DMSO demonstrated ΔAmax values
of 1.1% [0%, 2.5%] and 1.4% [0%, 4.1%] (nmedium = 63 and nDMSO = 71 colonoids), respectively,
which were both statistically different than the response of the forskolin-treated organoids (p <
0.0001 for all comparisons) (Video S3). On average, colonoids achieved 75% of their maximal
swelling within 23 min of forskolin addition and 100% of their maximal size within 46 min. The
estimated maximal rate of fluid movement in forskolin-treated colonoids during the 1 h assay
window was 4.23 ± 3.34 μLꞏh–1ꞏcm–2, which was significantly different than that estimated for
control colonoids (for medium addition, 1.50 ± 2.02 μLꞏh–1ꞏcm–2; for DMSO addition, 1.75 ± 1.93
μLꞏh–1ꞏcm–2; p < 0.0001 for all comparisons). The average initial net fluid flux was between 9%
and 30% that of the average maximal net fluid flux for colonoids in medium, DMSO, and forskolin.
Overall, the fluid transport rate of arrayed colonoids treated with forskolin was comparable to that
of 3D embedded cultures under the same conditions, which was 2.16 ± 0.55 μLꞏh–1ꞏcm–2. These
results suggested that cAMP-regulated ion transport followed by passive water movement occurs
in the arrayed colonoids.
The information-rich images of arrayed colonoids can be used for identification of heterogeneous
behaviors after a perturbation, such as application of a drug. For the forskolin-treatment
experiment described above, each colonoid’s size, swelling magnitude, and swelling kinetics were
quantified by a panel of 10 metrics (Supporting Information). To identify treatment-dependent
subpopulations of colonoids, the experimental data set, consisting of 66 forskolin-treated, 71
DMSO-treated, and 63 untreated colonoids, was clustered into two groups by k-means clustering
(Figure 3C,D). Forskolin-treated colonoids disproportionally fell into the responder cluster, which
was composed exclusively of 30 forskolin-treated colonoids. The remaining 36 forskolin-treated
and 134 non-forskolin-treated organoids clustered into a nonresponder group. Forskolin-treated
responders and nonresponders possessed ΔAmax values of 47.7% [35.8%, 63.7%] and 7.6%
[4.0%, 20.0%], respectively (Figure 3C,E). DMSO-treated colonoid nonresponders exhibited
ΔAmax values of 2.2% [0.5%, 6.0%] (Figure 3D,E). The maximum nonresponder ΔAmax was
20.5%, with 48% of forskolin-treated colonoids exceeding this swelling amount (8 nonresponders
and 24 responders out of 66 total forskolin-treated colonoids) (Figure 3E). These data
demonstrate the heterogeneity of colonoid swelling, even in response to the same stimulus,
forskolin, a direct activator of adenylyl cyclase.
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Figure 4. Colonoid swelling initiated by CT and compounds associated with the
enteric nervous and immune systems. (A) Box-and-whisker plots of the maximal
area attained by colonoids as a percentage of their area at time zero. The
colonoids were incubated with CT or its B subunit at the indicated concentrations
for 1.5 h. Colonoid responses to CT, C-B, and assay medium was statistically compared. (B) Two-
dimensional reduction of a 10-dimensional colonoid data set using principal component analysis. The data
set consisted of 768 colonoids across 16 wells of a 96-well plate treated with eight compounds and four
controls. For clarity, the nonresponding colonoids in negative control medium are omitted. All nonresponding
colonoids are shown in black, whereas colonoids with forskolin-like swelling responses are shown color-
coded by treatment compound. (C) Proportion of colonoids that exhibit swelling within a 32 min window in
response to compound treatment. Error bars represent ±1 standard deviation for three replicate experiments.
A support vector machine (SVM) classifier was trained for each replicate experiment by using that replicate’s
forskolin-treated and control colonoids as the classification’s positive and negative training groups,
respectively.
induced swelling using colonoids derived from four wild-type mice (3 male, 1 female) was
investigated (Figure S2). Arrayed colonoids grown from these mice were treated with forskolin,
while a control well received 0.1% DMSO-containing medium only. The median ΔAmax of forskolin-
treated colonoids from the four mice were 28.8% [20.5%, 33.1%], 15.1% [8.5%, 24.2%], 7.5%
[2.7%, 14.5%], and 20.2% [9.4%, 28.8%], while the matching ΔAmax values for the DMSO control
from these mice were 7.4% [4.3%, 10.3%], 5.6% [3.3%, 9.9%], 2.4% [0.9%, 4.9%], and 4.1%
[0.1%, 6.9%], respectively. The mean ΔAmax of all three samples was significantly different from
their respective DMSO controls (two-way ANOVA, p < 10–7 for all comparisons) as well as
between all four mice except between mice 1 and 4 (p < 0.05 for all comparisons) (Figure S2).
While a functional variation between animal tissue can be expected, colonoid swelling did increase
across all forskolin-treated samples relative to the paired DMSO control.
The dose dependence of forskolin-induced swelling in arrayed colonoids was then investigated
and compared to that of embedded cultures using colonoids from the same mouse. Both arrayed
and embedded colonoids demonstrated dose-dependent swelling for forskolin concentrations of
50 nM to 5 μM (Figure S3A). The dose responses were fit to sigmoidal logistic functions by
nonlinear regression with least-squares estimation (Figure S3B). For arrayed colonoids, the EC50
and maximal relative area increase of forskolin-induced swelling were 175.7 nM (95% confidence
interval (CI) = [52.4 nM, 299.0 nM]) and 344% (95% CI = [279%, 410%]), respectively. These
metrics were not significantly different from the EC50 and maximum response of embedded
colonoids from the same mouse, which were 232.4 nM (95% CI = [106.9 nM, 357.9 nM]) and
284% (95% CI = [248%, 321%]), respectively. Thus, overall forskolin-induced swelling in arrayed
colonoids was similar to that of hydrogel-embedded cultures.
The dose-dependent response to forskolin permits an estimate of the number of colonoids needed
to obtain a statistically significant swelling response as the forskolin concentration is altered. The
lowest forskolin concentration that induced a statistically different response relative to the control
was 250 nM (p < 0.001, two-way ANOVA), which induced 2.1- and 2.6-fold increases in median
ΔAmax over the DMSO control for embedded and arrayed colonoids, respectively. Based on these
data, the estimated total sample size required to detect statistically significant differences between
the ΔAmax of forskolin and DMSO-treated colonoids is 2868 for the expected 1.2× difference, 322
for a 1.5× difference, 80 for a 2.8× difference, and 42 for a 2.9× difference. Thus, even for a
moderate level of swelling (1.5-fold size increase), hundreds of colonoids must be screened for
statistical confidence. The use of arrayed organoid strategy enables the assay of sufficient
colonoids for these biologically relevant swelling conditions.
Investigation of Fluid Secretion by Cholera Toxin
Cholera is a well-known toxin that causes persistent diarrhea through cAMP production as well as
activation of enteric nervous and immune systems. The toxin consists of two units, A and B. The
combined toxin A + B (CT) is required to activate adenylyl cyclase and produce cAMP.(1) The B
subunit of cholera toxin (C-B) binds to intestinal epithelial cells but does not stimulate cAMP
production.(33) The impact of cholera toxin on colonoid arrays was investigated by adding CT,
C-B, or medium to the cultures and applying the automated platform to track the colonoids over
time. CT at both 0.5 and 5 μg/mL induced a significantly greater increase in ΔAmax than the
medium-only control or 0.5 or 5 μg/mL C-B (p < 0.01 for all comparisons; Figure 4A). There was
no statistical difference between wells treated with medium alone and wells treated with 0.5 or 5
μg/mL C-B (Figure 4A). These data demonstrate the utility of our platform in the measurement of
cellular responses to enterotoxins.
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Cell–enterotoxin interactions can activate enteric nervous and immune systems to produce
compounds that induce ion transport or inhibit ion absorption, with subsequent water movement
producing diarrhea and significant water loss through the colon.(1) To investigate the potency of
such compounds on fluid transport on intestinal cells, eight compounds [bradykinin, prostaglandin
E2, vasoactive intestinal peptide (VIP), adenosine, serotonin, acetylcholine, and histamine]
generated by enteric nerves or inflammatory cells during infectious diarrhea were selected for
screening on the primary arrayed colonoids (Table S1).(1) Colonoids at day 2 of culture were
incubated with each compound for 32 min while undergoing time-lapse imaging. Forskolin was
used as a positive control, while culture medium and C-B were included as negative controls.
Automated image analysis enabled each colonoid’s size, swelling magnitude, and swelling kinetics
to be quantified by a panel of 10 metrics (Supporting Information). We then proceeded to analyze
this rich data set for unique subpopulations. Support vector machine (SVM) classification was
used to distinguish between responsive and nonresponsive colonoids. For each well-plate
replicate, the forskolin-treated positive controls and standard medium negative controls were used
to train a linear SVM binary classifier, which had an estimated accuracy of 91.3%–94.5% when
distinguishing between swelling responders and static nonresponders. The effects of the screened
compounds on individual colonoid area and resulting classification for a single well plate are
shown in Figure S4. For the PGE2-treated sample, a large number of colonoids were identified as
responders (49.6% ± 17.9%, total 70 out of 139) (Figure 4 B,C, Video S4). This PGE2-responsive
subpopulation possessed a greatly increased median ΔAmax (16.2%) compared to that of PGE2
nonresponders (median ΔAmax 4.6%). PGE2 is known to be produced during infection with Vibrio
cholerae(34), leading to an increase in cAMP.(35) These results show that colonoids in the
cultures were not functionally equal. Previously, Magness and co-workers(36) have shown the
transcriptional heterogeneity of small intestinal organoids within the same culture. Small numbers
of colonoids treated with compounds other than forskolin or PGE2 were classified as responders
(1.9%, or 37 out of 1955 colonoids) (Figure 4B,C). These responding colonoids could represent
unique subpopulations within colonoids, but larger numbers of colonoids would need to be tracked
to ascertain whether such subpopulations exist. Overall, these data support the utility of the
arrayed colonoids when combined with automated imaging and computation as a screening
platform to identify the intestinal response to exogenous compounds such as drugs and toxins.
Conclusions
This paper demonstrates the development of an arrayed colonoid culture system on the surface of
a hydrogel support. The colonoids resided on a locally flat surface such that efficient automated
imaging was possible by use of a computer-controlled microscope. Moreover, the cell types and
polarity of the arrayed organoids were indistinguishable from hydrogel-embedded organoids.
Using simple and accessible automated image analysis methods, we demonstrated the
measurement of individual colonoid positions and sizes over time frames as long as 72 h. By this
approach, net fluid movement across the epithelial cell monolayer of the organoids was tracked
and quantified by using the colonoid cross-sectional area as a proxy. This image-based tracking of
organoid swelling was used to screen a small set of physiological molecules associated with the
enteric nervous and immune system for their impact on water movement across the colonoid
epithelium. Heterogeneity in organoid response to chemicals, such as forskolin and PGE2, and
toxins, such as cholera, was readily observed. For example, PGE2-treated colonoids displayed a
responsive subpopulation that possessed 3.5× higher response compared to that of PGE2
nonresponders. To detect smaller swelling responses, from 1- to 2-fold that of the control,
hundreds to thousands of colonoids are required to identify statistically significant responses. This
arrayed colonoid system readily permits large numbers of organoids to be assayed, thus allowing
small subpopulations to be identified. In this instance, 2248 colonoids were assayed in less than 4
h for the compound screen. We anticipate the utility of this arrayed colonoid culture for
applications involving screens of drugs, bacterial products, and dietary metabolites on primary
intestinal tissue. Further, we anticipate that this platform can be readily extended to culture human
intestinal organoids for personalized medicine applications.
Supporting Information
The Supporting Information is available free of charge on the ACS Publications website at DOI:
10.1021/acs.analchem.7b04032.
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